You are here

  • Home
  • Archive
  • Volume 29, Issue 2
  • Role of HPV genotyping in risk assessment among cytology diagnosis categories: analysis of 4562 cases with cytology–HPV cotesting and follow-up biopsies

Article info

Article menu
Download PDFPDF
Original Article
Role of HPV genotyping in risk assessment among cytology diagnosis categories: analysis of 4562 cases with cytology–HPV cotesting and follow-up biopsies

Authors

  1. Correspondence to Yimin Ge, Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Weill Cornell Medical College of Cornell University, Houston, TX 77030, USA; yge{at}houstonmethodist.org
View Full Text

Citation

Ge Y, Christensen P, Luna E, et al
Role of HPV genotyping in risk assessment among cytology diagnosis categories: analysis of 4562 cases with cytology–HPV cotesting and follow-up biopsies
International Journal of Gynecologic Cancer 2019;29:234-241.

Publication history

  • Received July 25, 2018
  • Revision received August 17, 2018
  • Accepted September 6, 2018
  • First published January 18, 2019.
Online issue publication 
August 17, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2019. No commercial re-use. See rights and permissions. Published by BMJ.